Zepbound, known generically as tirzepatide, is a prescription medication approved by the FDA for adults struggling with obesity or overweight conditions
The AST/ALT ratio above 2:1 may indicate more serious liver pathology
Unusually Low Pricing: While affordability is important, prices substantially below market rates may indicate quality compromises including use of lower-grade ingredients, inadequate quality control, or absence of proper medical supervision
Gallbladder events rise modestly, especially with rapid loss. Less common signals include skin dysesthesia, which is now on the label, and a small thyroid-cancer association in two population studies with a tiny absolute event rate. Depression and suicidality remain unproven
Just before our period arrives our uterine lining gets ready to shed
Delayed shipments without tracking updates caused frustration